(A) Representative images of microtubules (tubulin, green) and DNA (DAPI, blue) in HeLa cells synchronized in interphase (G2) and metaphase, as described in Figure 1A . Scale bars, 10 µm. (B) Immunoblot analysis of actin, cyclinB and phospho-Histone H3 (P-HH3) levels in synchronized cell extracts. (C) Fluorescent immunoblot of actin in the soluble fraction (S) versus the pellet (P) after optimization of lysis conditions. Percentages quantify the intensity of the actin bands. Extracts 1 and 2 correspond to two independent experiments. (D) Immunoblot analysis of phospho-CDK substrates in interphase and nocodazole-arrested mitotic cells with or without phosphatase inhibitors (PI) after different incubation conditions. RT=Room Temperature. (E) Immunoblot analysis of actin, cyclinB, P-HH3 levels in the synchronized cell extracts before and after 1 hour incubation at room temperature (conditions used for the phalloidin-bead pull-down). (F) Examples of scanning electron microscopy images of actin filaments in the synchronized cell extracts incubated with phalloidin in presence of ATP and MgCl 2 . Scale bars, 3 µm. (G) Colloidal Coomassie staining of SDS-PAGE gels of synchronized cell extracts, and of the control and phalloidin bead elutions, for one of the mass spectrometry experiments (MS1); similar data corresponding to the other mass spectrometry experiment (MS2) is displayed in Figure 1D . The x marks an unrelated lane. Immunoblot analysis of the levels of a subset of proteins found in the mass spectrometry analysis, in soluble fractions of cell extracts synchronized in G2 and Metaphase. GAPDH loading controls are identical for Caldesmon/WDR1 and for Fascin-Filamin/Vimentin-CFL-1, as the corresponding stainings were done on the same gel. (A) Representative images of rounded interphase (right) and mitotic (left) HeLa cells stained for vimentin and F-actin. DAPI staining was used to identify interphase cells. Scale bar, 10 µm (B) Representative maximum z-projections of confocal stacks across mitotic HeLa cells treated with DMSO, CDK1 inhibitor or PLK1 inhibitor and stained for total vimentin (see Video S3 for 3D visualizations). Scale bar, 10 µm (C) Left: Representative images of mitotic HeLa cells immunostained for phospho-56 or phospho-83 vimentin and total vimentin (VIM). Right: quantification of phospho-56 or phospho-83 vimentin enrichment at the cell cortex. Graph: mean ± standard deviation, 3 independent experiments. Vimentin total and phospho-56: n= 33; Vimentin total and phospho-83: n= 28. Unpaired t-test. Scale bars, 5 µm. (D) Immunoblot analysis of the levels of GFP-Vimentin in extracts of HeLa cells stably expressing different GFP-Vimentin mutants. NT: Non-transfected. (E) Representative images of interphase HeLa cells stably expressing different GFP-vimentins (WT and mutants as indicated). Scale bar, 10 µm. (F) Left: Representative images of GFP-vimentin (WT and mutants as indicated) localization in mitotic HeLa cells stably expressing GFP-vimentin WT or mutants. Right: quantification of GFP enrichment at the cell cortex. Graph: mean ± standard deviation, 3 independent experiments. WT: n= 31; 56A: n= 31; 56E: n= 33; 83E n= 29. Kruskal-Wallis test; ns=non-significant. Scale bar, 5 µm. (G) Effects of the ROCK inhibitor Y27632 in laser ablation experiments in HeLa cells expressing GFP-Vimentin-WT. The treatment with ROCK inhibitor abolished the occurrence of blebs (corresponding to 5 cells out of 27 in control condition compared to 1 cell out of 60 in Y27632 treated cells) confirming it effectively reduces cortex contractility, and strongly reduced the proportion of cells displaying surface flattening upon ablation; 18% of Y27632-treated cells still displayed visible surface flattening (vs. 45.5% in control cells), possibly because Y27632 treatment reduces but does not entirely abolish cortical tension (Tinevez et al PNAS 2009) . (H) Mitotic timing (from nuclear envelope break down to anaphase onset) in control and vimentin-depleted cells unconfined (no gel), and confined under 5 kPa gels. Graph: median and interquartile range. No gel: siNTC: n= 46; siVIM: n= 46; 5 KPa gel: siNTC: n= 122; siVIM: n= 102; at least 3 independent experiments. ANOVA non-parametric Kruskal-Wallis test; ns, non-significant.
